‘Magic Mushroom’ Drug Shows Promise in Treating Addictions and Cancer Anxiety

Health & Family

Suspended for decades after controversial results, research on the hallucinogen psilocybin is showing early promise in a new series of small studies.

In research presented at the annual meeting of the American College of Neuropsychopharmacology (ACNP), scientists highlighted the latest findings on the use of psilocybin, the synthetic version of the active compound in “magic mushrooms,” as a treatment for anxiety in terminal cancer patients, in smoking cessation and as a treatment for alcoholism.

Some of the studies are not complete and have not yet been reviewed by other experts, but they provide new information on psilocybin’s effects. Psilocybin is the active ingredient in over 100 species of mushrooms in the Psilocybe class, used for hundreds of years in shamanic ceremonies and other rituals in South America.

(MORE: ‘Magic Mushrooms’ Trigger Lasting Personality Change)

Research conducted during the 1950s and early ’60s into possible therapeutic…

View original post 771 more words

1 comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: